# Regeneron Pharmaceuticals, Inc. (REGN) — Q1-2016 Earnings Results

**Report date:** 2016-05-05 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q1-2016

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Beats on EPS, Stock Up 4.74%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.57 | N/A | +107.26% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Confident

Overall, management conveyed confidence in the company's direction and product pipeline. They emphasized the importance of innovation in driving future success.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They expressed optimism about future growth opportunities.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Regeneron's strong EPS performance, significantly exceeding expectations, led to a positive stock reaction, with shares rising by 4.74%. The company did not provide revenue figures or future guidance, but management's confident tone suggests they are optimistic about their product pipeline and growth potential. Investors may view this as a positive indicator for the company's future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q1-2016_